Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
about
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposureAdverse effects of antiretroviral therapy for HIV infectionHepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case reportIncidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER CohortNon-AIDS definings malignancies among human immunodeficiency virus-positive subjects: Epidemiology and outcome after two decades of HAART eraDrug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseaseThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureN-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocolTherapeutic issues in HIV/HCV-coinfected patientsHigh prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in ChinaUnhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis CHepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyTuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South AfricaAdverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medicationDiagnosis, management, and treatment of hepatitis C: an updateMELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection.Hepatic profile analyses of tipranavir in Phase II and III clinical trialsHepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection TreatmentEpidemiology of Hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years.Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status.Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicityScreening for hepatitis C among HIV positive patients at Mulago hospital in Uganda.Hepatic safety and tolerability of raltegravir among HIV patients coinfected with hepatitis B and/or CHepatitis C virus/human immunodeficiency virus coinfection: clinical management issues.Epidemiology of idiosyncratic drug-induced liver injuryReciprocal interaction of human immunodeficiency virus and hepatitis C virus infectionsHepatitis B vaccine by intradermal route in non responder patients: an update.Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAARTCoinfection with HIV and HCV: more questions than answers?Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective.Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir.Hepatitis B and hepatitis C co-infection in patients with HIV.Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection.Liver disease in the HIV-infected individual.Human immunodeficiency virus-hepatitis C coinfection: swapping new problems for newer ones.Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré.Retrospective evaluation of the effect of valproate therapy on transaminase elevations in patients with hepatitis C.
P2860
Q24243119-55609C4D-BD8A-41DB-9086-3A5B43785E11Q24617882-C224F139-1C24-480C-A5FF-02B27AFA0895Q24793365-FDF73B1F-0271-4ECF-ABFF-CB71FEC4A022Q24814420-C64B56FF-920C-4B17-8198-851F774E7821Q26797897-86814AAC-FC62-4375-9F49-1972DAC462E3Q26798157-B1050AE1-CCEC-4667-82C8-D07469E67F77Q26864344-C9019BC1-4339-4335-8BD8-CBF88C42E7B3Q27014948-C87464DA-E76D-4F35-AA23-87E7727463F1Q27481053-30D9E08F-59A5-425F-AB82-F871292594D1Q28474105-FCC8EDE2-15AC-47A7-8DB7-B5CF985E8EA3Q28484313-FB285A7A-6290-4A6E-9951-EECE42F20849Q28484920-E782C849-E2D1-44B3-8A9E-94B35B295ACBQ28543376-F21B87D0-4A35-4CFB-AD31-540630AE8599Q28749406-3CF10C18-6806-4F35-8139-9A1D8A8A2C0BQ29619682-23DD3672-43C3-470B-9714-C5CA5A2A6527Q30433644-AE94EAC2-E61A-4C04-8C76-3D148EC7023FQ30843946-0DAB2071-D8FD-439F-A474-02CBCCA622A7Q33378514-2E110273-CC6B-4FD1-80BD-5FE6485F9AD2Q33518011-53766AEC-BB3A-4183-B0D2-A728680C7636Q33576161-B2E33C9D-0C1F-4B49-8B75-660E9FC61417Q33587716-57865F57-CADF-41D9-8D97-BE0D29FCB2D6Q33609481-4CAA36F1-9F21-4974-8810-30CC181F8663Q33799279-5E13534B-D64E-439D-88C8-6232C3057BE5Q33918653-101D636F-7F8C-4C04-B44A-EDCD3F258C3EQ33940800-0D6D068D-58C1-4544-9A5B-1FEC13FC014DQ33982898-ADA25062-F9D8-489A-AF70-C2FFFBFA1B5FQ33990236-F38F17B8-38F0-417D-A397-EA9C9A88349DQ33999381-3E43EB84-E82E-4506-A8E7-F48141178680Q34036643-E8D40D30-CDD3-45BE-AAAD-A475F5A7370EQ34070485-0A67BD68-FCE7-4531-BD9D-E07E922DEA53Q34113786-BB4C0E5D-AE2D-42D0-9251-6A86B020E669Q34157953-7FDC49E2-453C-453C-BA61-282BE8D1FE89Q34260569-BD630F9E-22E4-454C-8496-0145639DDED9Q34310482-A3C500CC-3A97-4078-AEBC-E79F9C3AC15EQ34323219-FB2E46BB-401A-4008-AB38-879DB30B59CDQ34349036-D609B44E-DD42-4024-8FEC-4AEB3432F94EQ34380326-AA385432-1C11-4785-98C2-CE16B9E58F02Q34390060-26CDB09C-7645-4650-9B78-C9922CB45FA1Q34391514-0BAEA3E3-B7C8-47E2-A0F9-2EC740AABEB9Q34443321-716733E3-66FD-4B04-83C9-D2C14DBFF9A4
P2860
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Hepatotoxicity associated with ...... atitis C or B virus infection.
@en
Hepatotoxicity associated with ...... atitis C or B virus infection.
@nl
type
label
Hepatotoxicity associated with ...... atitis C or B virus infection.
@en
Hepatotoxicity associated with ...... atitis C or B virus infection.
@nl
prefLabel
Hepatotoxicity associated with ...... atitis C or B virus infection.
@en
Hepatotoxicity associated with ...... atitis C or B virus infection.
@nl
P2093
P356
P1476
Hepatotoxicity associated with ...... atitis C or B virus infection.
@en
P2093
D L Thomas
M S Sulkowski
R E Chaisson
P356
10.1001/JAMA.283.1.74
P407
P577
2000-01-01T00:00:00Z